Changes in neurocognitive function and central nervous system structure in childhood acute lymphoblastic leukaemia survivors after treatment: a meta‐analysis-Reference-Cited by-同舟云学术

Changes in neurocognitive function and central nervous system structure in childhood acute lymphoblastic leukaemia survivors after treatment: a meta‐analysis

Published:2019-12-10 Issue:6 Volume:188 Page:945-961
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhou Chendan¹,Zhuang Yong¹,Lin Xingjie¹,Michelson Alan D.²,Zhang Aijun¹²^ORCID

Affiliation:

1. Department of Pediatrics Qilu Hospital Shandong University Jinan Shandong China

2. Dana‐Farber/Boston Children’s Cancer and Blood Disorders Center Harvard Medical School Boston MA USA

Funder

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16279

Reference58 articles.

1. Neurocognitive late effects of chemotherapy in children: The past 10 years of research on brain structure and function

2. White Matter Fractional Anisotropy Correlates With Speed of Processing and Motor Speed in Young Childhood Cancer Survivors

3. Cognitive and Academic Late Effects Among Children Previously Treated for Acute Lymphocytic Leukemia Receiving Chemotherapy as CNS Prophylaxis

4. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: Effect of treatment intensity

5. A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attention and executive functioning in children and adolescents treated for high‐risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG);Pediatric Blood & Cancer;2024-08-23

2. Cognitive performance and brain volume among survivors of pediatric hematological malignancies: a case–control study;Clinical and Translational Oncology;2024-08-12

3. Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL);Current Treatment Options in Oncology;2024-08-05

4. Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study;Journal of Clinical Oncology;2024-08-01

5. Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study;Cancers;2024-03-19